See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

Aileron Ads $33M In Series E Round

Aileron Therapeutics, a nine-year-old, Hardwick, Ma.-based company that develops a class of drugs called stapled peptides, has added $33 million to its Series E round, bringing total funding for the round to $48 million.


More from